SpringWorks Therapeutics Inc (SWTX)
43.38
-0.62
(-1.41%)
USD |
NASDAQ |
Apr 24, 16:00
43.32
-0.06
(-0.14%)
After-Hours: 20:00
SpringWorks Therapeutics Total Liabilities (Quarterly): 99.57M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 99.57M |
| September 30, 2023 | 72.76M |
| June 30, 2023 | 65.89M |
| March 31, 2023 | 62.27M |
| December 31, 2022 | 72.05M |
| September 30, 2022 | 69.15M |
| June 30, 2022 | 40.18M |
| March 31, 2022 | 28.78M |
| December 31, 2021 | 30.10M |
| September 30, 2021 | 28.60M |
| Date | Value |
|---|---|
| June 30, 2021 | 23.84M |
| March 31, 2021 | 19.89M |
| December 31, 2020 | 19.13M |
| September 30, 2020 | 13.34M |
| June 30, 2020 | 10.15M |
| March 31, 2020 | 9.274M |
| December 31, 2019 | 12.76M |
| September 30, 2019 | 11.08M |
| June 30, 2019 | 11.00M |
| December 31, 2018 | 67.76M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.274M
Minimum
Mar 2020
99.57M
Maximum
Dec 2023
36.83M
Average
28.60M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Syndax Pharmaceuticals Inc | 58.68M |
| Alnylam Pharmaceuticals Inc | 4.051B |
| Geron Corp | 146.13M |
| Ionis Pharmaceuticals Inc | 2.603B |
| Madrigal Pharmaceuticals Inc | 235.21M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 725.79M |
| Shareholders Equity (Quarterly) | 626.22M |
| Current Ratio | 6.408 |